GGrantIndex
Sort

141,003 grants matching cytokine

New Strategies to Prevent Death from Influenza

$1,196,788
Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2010 · AI

Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience

$1,196,449
Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · U19 · FY2021 · AT

Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications

$1,196,407
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA

Disappearing gastrointestinal microbiota in epidemic obesity.

$1,196,335
Martin J Blaser · New York University School Of Medicine · R01 · FY2015 · DK

Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP

$1,195,794
Mark Connors · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Molecular Genetics Of Heritable Human Disorders

$1,195,691
Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Molecular Biology: Viral Glial Gene Interaction in Brain

$1,195,635
Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2006 · NS

Project 1: Mechanisms of Disease Progression

$1,195,053
Alan A Aderem · Seattle Children'S Hospital · U19 · FY2019 · AI

Restoration of free radical homeostasis: novel therapy of septic shock

$1,194,948
Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2017 · GM

GrowthDifferentiation Factors in Organogenesis

$1,194,902
Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

P01-Pathogenesis and Prevention of Osteoporosis

$1,194,799
University Of Connecticut Sch Of Med/Dnt · P01 · FY2002 · AR

New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity

$1,194,659
Franco Vitaliano · Exqor Technologies, Inc. · R44 · FY2021 · DA

Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV

$1,194,567
Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2016 · HL

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,194,199
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

A Controlled Trial of CBT for Multiple Sclerosis Inflammation

$1,193,863
David I. Daikh · Northern California Institute/Res/Edu · R01 · FY2007 · HD

First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation

$1,193,602
Linda J Van Eldik · University Of Kentucky · R01 · FY2021 · AG

Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk

$1,193,316
Yousin Suh · Columbia University Health Sciences · R01 · FY2020 · DK

Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses

$1,193,316
Zhi-Ming Zheng · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Oligodendroglial Interactions Group

$1,193,279
Tobias Merson · National Institute Of Mental Health · ZIA · FY2025 · MH

Effects of cornea epithelial barrier disruption on the cornea trigeminal neural circuit

$1,193,265
Stephen Carl Pflugfelder · Baylor College Of Medicine · U01 · FY2022 · EY

Inhalation Repurposing of An Approved Drug to Treat Severe Asthma

$1,193,081
John Sullivan · Aeon Respire, Inc. · R44 · FY2022 · HL

Cancer Biology and Genetics

$1,193,000
Harold Varmus · National Human Genome Research Institute · ZIA · FY2014 · HG

Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience

$1,192,792
Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AT

Hormone Receptors and Genes Regulating Gonadal and mammary function

$1,192,561
Maria Dufau · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD

Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes

$1,192,518
Hubert M Tse · University Of Kansas Medical Center · R01 · FY2023 · DK